The Case for Cannabidiol-Integration of Eastern and Western Medical Traditions and the Promise for the Future: A Narrative Review and Commentary

Pharmacognosy Reviews,2025,19,37,119-126.
Published:June 2025
Type:Review Article
Authors:
Author(s) affiliations:

Peter Pressman1,*, Julia Hoeng2, Pornchai Padmindra3, Sakan Warinhomhoun4, Wallace Hayes5

1Medicine and Social Sciences, The University of Maine, Orono, Maine, UNITED STATES OF AMERICA.

2Vectura Fertin Pharma, 4058 Basel, SWITZERLAND. 3DR CBD, Ltd., BangnaNuea, Bagna, Bangkok, THAILAND. 4College of Oriental Medicine, Rangsit University, Pathum Thani, THAILAND. 5College of Public Health, University of South Florida, Tampa, Florida, UNITED STATES OF AMERICA.

Abstract:

Our intent in the following narrative review and commentary is to underscore the importance of critically re-exploring ancient and enduring medical traditions. We support a view that rediscovering and augmenting the elements of the past, especially in the context of Eastern traditions, will inform and strengthen the global future. In the absence of the historical and multicultural perspective, it could be argued that we have become rather myopic or focused within discrete silos; we seem continually to re-invent the wheel in successively refined form, without truly evaluating foundations, traditions, and history of use. This situation suggests that technologically sophisticated investigators and clinicians are not necessarily aware of the full spectrum of the safety, efficacy, clinical indications, and guidelines for the use of many naturally sourced pharmacologic formulations with a remarkably long history of widespread use, and with implications for valuable and innovative drug development. We discuss Cannabidiol (CBD) as illustrative of such an opportunity.

Cite This Article

Vancouver Style ::
P. Pressman, Hoeng, J. , Padmindra, P. , Warinhomhoun, S. , and Hayes, W. , The Case for Cannabidiol-Integration of Eastern and Western Medical Traditions and the Promise for the Future: A Narrative Review and Commentary, Pharmacognosy Reviews, vol. 19, no. 37, pp. 119-126, 2025.